Cargando…

Potential objective diagnostic biomarker platform of serum proteins for major depressive disorder:a preliminary exploration

INTRODUCTION: Major depressive disorder (MDD) is a severe, disabling condition with unknown etiology. Misdiagnosis is common when clinical symptomology criteria are used solely. Considerable evidence suggests that the upregulation of inflammatory factors and cortisol, and a decrease in neurotrophic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, S., Zhang, Y., Yuan, Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471375/ http://dx.doi.org/10.1192/j.eurpsy.2021.871

Ejemplares similares

Drug Induced Bullous Lesion Caused By Valproic Acid in Bipolar Affective Disorder:A Case Report
por: Polat, H. D., et al.
Publicado: (2023)

Pharmacotherapy of restricted/repetitive behavior in autism spectrum disorder:a systematic review and meta-analysis
por: Yu, Yanjie, et al.
Publicado: (2020)

Potential of antithrombin III as a biomarker of antidepressive effect in major depressive disorder
por: Song, R., et al.
Publicado: (2021)

The Influence of Depression and School Life on the Quality of Life of Korean Child and Adolescent Patients with Attention-Deficit/Hyperactivity Disorder:A Comparison of the Perspectives of the Patients and Their Caregivers
por: Park, Byeong-Eon, et al.
Publicado: (2019)

PS194. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder
por: Kim, Eun Young, et al.
Publicado: (2016)

PS46. Distinct and shared morphometric biomarkers of depressed individuals with bipolar disorder and major depressive disorder
por: Matsuo, Koji, et al.
Publicado: (2016)

Childhood trauma influences the age of onset and severity of major depressive disorder via brain function
por: Chen, S., et al.
Publicado: (2021)

Regionally decreased cortical gyrification in patients with major depressive disorder
por: Han, K.-M., et al.
Publicado: (2023)

Linked patterns of symptoms and cognition with brain controllability in major depressive disorder
por: Li, Q., et al.
Publicado: (2023)

PS50. The serum oxytocin levels among major depressive and bipolar II disorder
por: Lien, Yueh-Ju, et al.
Publicado: (2016)

PS173. A prospective study of structural connectivity in adolescents with major depressive disorder: A preliminary study
por: Lee, Moon-Soo, et al.
Publicado: (2016)

PS97. Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Brain aging in major depressive disorder
por: Han, L., et al.
Publicado: (2021)

quality of remission in the major depressive disorder
por: Chebli, H., et al.
Publicado: (2023)

Temperament and major depressive disorder
por: Karam, Elie G, et al.
Publicado: (2010)

Care pathways for people with major depressive disorder
por: Strawbridge, R., et al.
Publicado: (2022)

Atopic Dermatitis and Major Depressive Disorder: is there causality?
por: Reis, C. S., et al.
Publicado: (2023)

Serum CC Chemokines as Potential Biomarkers for the Diagnosis of Major Depressive Disorder
por: Gao, Wenfan, et al.
Publicado: (2022)

Gender Differences in Developing Biomarker-Based Major Depressive Disorder Diagnostics
por: Jentsch, Mike C., et al.
Publicado: (2020)

Depression in men with testosterone deficiency (Preliminary results of the study)
por: Osadshiy, Y., et al.
Publicado: (2022)

The Role of Base Excision Repair in Major Depressive Disorder and Bipolar Disorder
por: Kucuker, M., et al.
Publicado: (2022)

Telomere attrition and inflammatory load in major depressive disorder
por: Squassina, A.
Publicado: (2021)

Probiotics as a therapeutic strategy in Major Depressive Disorder
por: Vargas, L.
Publicado: (2022)

Major depressive disorder with anxious features - the role of pregabalin
por: Carvalho, R. S., et al.
Publicado: (2023)

The establishment of the objective diagnostic markers and personalized medical intervention in patients with major depressive disorder: rationale and protocol
por: Lv, Xiaozhen, et al.
Publicado: (2016)

Adolescent oral contraceptive use and future major depressive disorder
por: Wit, A. De, et al.
Publicado: (2021)

Search for serum biomarkers in patients with bipolar disorder and major depressive disorder using metabolome analysis
por: Sun, Xiao-Li, et al.
Publicado: (2023)

Association between inflammation and neural plasticity biomarkers in olfactory neuroepithelium – derived cells and cognitive performance in patients with major depressive disorder
por: Toll, A., et al.
Publicado: (2022)

A preliminary composite of blood-based biomarkers to distinguish major depressive disorder and bipolar disorder in adolescents and adults
por: Huang, Jieping, et al.
Publicado: (2023)

SOD and CAT as potential preliminary biomarkers for the differential diagnosis of schizophrenia and bipolar disorder in the first episode of psychosis
por: Cachán-Vega, C., et al.
Publicado: (2023)

The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD) The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD) The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD)
por: Pieters, T., et al.
Publicado: (2022)

PS203. The correlation between high-density lipoprotein and serum brain-derived neurotrophic factor levels in patients with major depressive disorder
por: Yang, Meng Fan, et al.
Publicado: (2016)

PS92. Serum BDNF and GDNF levels before and after the 12-week antidepressant treatments among outpatients with major depressive disorder
por: Lee, Bun-Hee, et al.
Publicado: (2016)

Major depressive disorder (MDD) in adolescents with Borderline (BPD) and Shyzotypal personality disorder (STPD)
por: Kaleda, V., et al.
Publicado: (2023)

Structural neuroimaging differentiates between depressed bipolar disorder and major depressive disorder patients: a machine learning study
por: Calesella, F., et al.
Publicado: (2023)

Depression and Decay - A Case of Major Depressive Disorder with Psychotic Features in an Elderly Patient with Cancer
por: Wee Yun Qing, E.
Publicado: (2023)

The effects of Cumulative Trauma and Cognitive Rigidity on the Severity of Depressive Disorder: Preliminary Results
por: Salla, M., et al.
Publicado: (2022)

Exploring the paradigm of depressive disorders through an evolutionary and biopsychosocial lens
por: Ochi, T., et al.
Publicado: (2023)

PS96. The change of prescribing patterns for inpatients of major depressive disorder
por: Kim, Hyeri, et al.
Publicado: (2016)

Theory and Practice of Treatment of Concurrent Major Depressive and Alcohol Use Disorders
por: Samokhvalov, A.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_imtpol3l31ii409qm01l17lbl8